Research Article

Amiselimod (MT-1303), a Novel Sphingosine 1-Phosphate Receptor-1 Modulator, Potently Inhibits the Progression of Lupus Nephritis in Two Murine SLE Models

Figure 2

Effect of MT-1303 on anti-DNA antibody levels and plasma cells in MRL/lpr mice. MT-1303 was orally administered to MRL/lpr mice daily from 8 to 18 weeks of age. The serum and spleen were obtained the day after the final administration, and serum anti-dsDNA antibody levels (a) were determined by ELISA. Results are expressed as the of 12 mice. The number of plasma cells in the spleen (b) was determined by flow cytometry. Results are expressed as the of 4 mice. Statistical differences were calculated using the Williams test by comparison with the control (, ).
(a)
(b)